Does BIMEKIZUMAB Cause Therapy interrupted? 138 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Therapy interrupted have been filed in association with BIMEKIZUMAB (Bimzelx). This represents 5.6% of all adverse event reports for BIMEKIZUMAB.
138
Reports of Therapy interrupted with BIMEKIZUMAB
5.6%
of all BIMEKIZUMAB reports
1
Deaths
31
Hospitalizations
How Dangerous Is Therapy interrupted From BIMEKIZUMAB?
Of the 138 reports, 1 (0.7%) resulted in death, 31 (22.5%) required hospitalization, and 2 (1.4%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB Cause?
Psoriatic arthropathy (615)
Psoriasis (400)
Drug ineffective (293)
Inappropriate schedule of product administration (238)
Injection site pain (225)
Product dose omission issue (163)
Off label use (160)
Oral candidiasis (146)
Fatigue (138)
Pneumonia (118)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which BIMEKIZUMAB Alternatives Have Lower Therapy interrupted Risk?
BIMEKIZUMAB vs BIMEKIZUMAB-BKZX
BIMEKIZUMAB vs BINIMETINIB
BIMEKIZUMAB vs BIOFLAVONOIDS
BIMEKIZUMAB vs BIOTIN
BIMEKIZUMAB vs BIPERIDEN